Office of Biostatistics and Epidemiology

Immediate Office
  • Steve Anderson, PhD - Risk Assessment Research: Development of Tools that Evaluate and Enhance the Safety of Biologic Products

Division of Biostatistics

  • Tie-Hua Ng, PhD - Research in statistical methodology for equivalence testing, interim analysis and migration studies
  • Jawahar Tiwari - Evaluation of bioinformatics tools for the analysis of pharmacogenomic and proteomic data from regulatory clinical and non-clinical studies
  • Weishi (Vivian) Yuan, PhD - Adaptive Designs for Clinical Trials
  • Boris Zaslavsky, PhD - Statistical and bioinformatics tools for the analysis of blood products and pharmacogenomic and proteomic data

Division of Epidemiology

  • M. Miles Braun, MD - Director - Applied Public Health Safety Studies of Biologic Products
  • Robert Ball, MD - Post-marketing Monitoring of Vaccine Safety
  • Dale R. Burwen, MS - Evaluating the safety of influenza and pneumococcal vaccines received by the Medicare population
  • Ann W. McMahon, MD - Determinants of Acceptance of Smallpox Vaccination
  • Emily Jane Woo - Study of swelling and other reactions to evaluate safety of diphtheria-tetanus-acellular pertussis vaccine
 
Updated: January 30, 2008